A Pilot Study of Chondroitin Sulfate (CS) for the Treatment of Mild to Moderate Crohn's Disease
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Chondroitin sulfate (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 31 Aug 2012 Biomarkers information updated
- 01 May 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 03 Dec 2010 New trial record